OmniComm Introduces TrialOne: An Integrated Suite of Web Based Solutions for Phase I Clinic Automation and Management
OmniComm Systems, Inc. (OTC: OMCM.OB), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS .NET, web‐based solution designed to automate the Phase I Clinical Trial Process. TrialOne provides web‐based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real‐time data, track sample transfers and address the unique requirements of early phase studies. Within each study, real‐time electronic data is captured and validated at the subject’s bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab. TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare DINAMAP® family of vital signs monitors and various ECG devices.
TrialOne enables Phase I Clinics to share data with other stakeholders via the internet and provides a flexible ad‐hoc reporting tool to help export and report data in various formats including Adobe® PDF, Microsoft® Excel and Word. Further extensibility of the TrialOne suite via integration to our flagship EDC product, TrialMaster®, using OmniConnect™, our enhanced web services API, and an integrated pharmacy module is planned for release later this year.
“TrialOne is the only available product that handles all aspects of the Phase I process from subject recruitment and clinical wokflow management to laboratory sample management,” said OmniComm’s CTO, Randy Smith.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
